Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01029288 · ClinicalTrials.gov registry record · NA

Impact of Decision Aids to Enhance Shared Decision Making for Diabetes

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
110
Enrollment target

NCT01029288: Completed NA study, sponsored by Mayo Clinic.

NCT01029288 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01029288, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
110 participants
Enrollment target

Study Summary

The proposed trial seeks to determine the impact of patient decision aids versus usual care on measures of patient involvement in decision-making, diabetes care processes, medication adherence, glycemic and cardiovascular risk factor control, and resource utilization in nonurban practices in the Midwestern United States. Upon completion of this trial, the investigators will have new knowledge about both the effectiveness of diabetes decision aids in nonacademic nonurban practices and about the processes that promote or inhibit the successful implementation of patient decision aids in such practices.

Interventions

  • OTHER Diabetes Medication Choice Decision Aid
  • OTHER Statin Choice Decision Aid
  • OTHER Usual care for lipid therapy medication
  • OTHER Usual care for antihyperglycemic medication

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2010-04
Est. Completion 2013-01
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT01029288 record still lists

NCT01029288 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 4 interventions - of which Diabetes Medication Choice Decision Aid is the first listed.

NCT01029288 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01029288 about?

NCT01029288 is a clinical study titled "Impact of Decision Aids to Enhance Shared Decision Making for Diabetes". The proposed trial seeks to determine the impact of patient decision aids versus usual care on measures of patient involvement in decision-making, diabetes care processes, medication adherence, glycemic and cardiovascular risk factor control, and resource utilization in nonurban practices in the Mid...

What is the current status of trial NCT01029288?

This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2010-04. Estimated completion is 2013-01.

What interventions are being tested in trial NCT01029288?

The interventions under investigation include: Diabetes Medication Choice Decision Aid (OTHER), Statin Choice Decision Aid (OTHER), Usual care for lipid therapy medication (OTHER), Usual care for antihyperglycemic medication (OTHER).

Who is sponsoring clinical trial NCT01029288?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01029288's enrollment target sits among peer trials

110 816th of 2000 higher than 1,176 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01029288, the US trial registry maintained by the National Library of Medicine. NCT01029288 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.